DIABETIC NEUROPATHIC PAIN
DOI:
https://doi.org/10.21776/ub.jphv.2021.002.01.3Keywords:
Diabetes, neuropathic pain, hyperglychemia, anticonvulsant, antidepressant.Abstract
Diabetic Neuropathy is the most common complication from diabetes, which experienced in almost 90% diabetes patient. Evenly pain is one of the most common symptoms of diabetic neuropathic, but the pathophysiology mechanism of pain is not clearly known. The hyptosesis of toxicity of hyperglycemia on development of pain complication has been widely accepted globally, but there is other proposed hypothesis. Basic concept in management of painful diabetic neuropathic is exclusion of the other cause of painful peripheral neuropathy, improving glycemic control for prophylaxis therapy and medication use for alleviating pain. The first choice drug of therapy for alleviating pain are anticonvulsant, like pregabalin and gabapentin, and antidepressant, mainly that work on inhibiting serotonine and noradrenaline reuptake. In conclusion, the better understanding of painful diabetic neuropathic underlying mechanism can help to find a better management that improving the guideline quality in optimalizing pain control.
References
Atlas D. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation; 2015
Tesfaye S, Boulton AJ, & Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care; 2013. 36(9):2456-2465. DOI: 10.2337/dc12-1964
Schreiber AK, Nones CF, Reis RC, Chichorro JG & Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World Journal of Diabetes; 2015. 6(3):432–444.
DOI: https://doi.org/10.4239/wjd.v6.i3.432
Richard PA, Daniel LP, William GO. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance, Sleep Medicine; 2014. 15(8.2014):860-873. ISSN 1389-9457.
DOI: https://doi.org/10.1016/j.sleep.2014.03.025.
Kalra S & Gupta A. Diabetic painful neuropathy and restless legs syndrome in diabetes; 2018.
DOI: https://doi.org/10.1007/s13300-018-0376-6
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, & Ziegler D. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care; 2017. 40(1):136-154. DOI: https://doi.org/10.2337/dc16-2042
Juster-Switlyk K, & Smith AG. Updates in diabetic peripheral neuropathy. F1000Research; 2016.5.
DOI: 10.12688/f1000research.7898.1
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, & Viswanathan V. Diabetic neuropathy. Nature Reviews Disease Primers; 2019. 5(1):1-18. DOI :10.1038/s41572-019-0097-9.
Hanewinckel R, Drenthen J, Ligthart S, Dehghan A, Franco OH, Hofman A, ... & van Doorn PA. Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: A prospective population-based cohort study. Journal of Neurology, Neurosurgery & Psychiatry; 2016. 87(12):1336-1342.
DOI: http://dx.doi.org/10.1136/jnnp-2016-314171
Callaghan BC, Price RS & Feldman EL. Distal symmetric polyneuropathy: A review. JAMA; 2015. 314:2172–218. DOI:10.1001/jama.2015.13611
Javed S, Petropoulos IN, Alam U, & Malik RA. Treatment of painful diabetic neuropathy. Therapeutic Advances In Chronic Disease; 2015. 6(1), 15–28.
DOI: https://doi.org/10.1177/2040622314552071
Shillo P, Sloan G, Greig M, Hunt L, Selvarajah D, Elliott J, ... & Tesfaye S. Painful and painless diabetic neuropathies: What is the difference? Current Diabetes Reports; 2019. 19(6):32.
DOI: https://doi.org/10.1007/s11892-019-1150-5
Petropoulos IN, Ponirakis G, Khan A, Almuhannadi H, Gad H, Malik RA. Diagnosing diabetic neuropathy: Something old, something new. Diabetes & Metabolism Journal; 2018 Aug;42(4):255-69.
DOI: https://doi.org/10.4093/dmj.2018.0056
Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy. Clinical Therapeutics; 2018. Jun;40(6):828-49.
DOI: https://doi.org/10.1016/j.clinthera.2018.04.001
Yorek M, Malik RA, Calcutt NA, Vinik A, Yagihashi S. Diabetic neuropathy: New insights to early diagnosis and treatments. Journal of Diabetes Research; 2018 DOI: https://doi.org/10.1155/2018/5378439
Hershey DS. Diabetic peripheral neuropathy: Evaluation and management. The Journal for Nurse Practitioners; 2017. Mar 1;13(3):199-204. DOI: http://dx.doi.org/ 10.1016/j.nurpra.2016.08.034
Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgraduate Medical Journal; 2006 Feb 1;82(964):95-100. DOI: 10.1136/pgmj.2005.036137
Hanik H. Carbamazepine as a pain treatment of trigeminal neuralgia. Journal of Pain, Headache and Vertigo (JPHV); 2020. 1(2):37-41.
DOI : https://doi.org/10.21776/ub.jphv.2020.001.02.4
Badrul M, Widodo MS, Zamroni A, Shahdevi NK. Radiofrequency as pain interventional therapy in neurology. Journal of Pain, Headache and Vertigo (JPHV); 2020. 1(2):31-36.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under aÂ
Creative Commons Attribution-NonCommercial 4.0 International License
